Researchers have identified metabolites in the human microbiome that inhibit COVID-19 infection in cell-based models of the virus.
A new study published in Microbiology Spectrum demonstrates a significant step forward for achieving rapid test COVID-19 results on a large scale, while preserving supplies and reducing cost.
A new study in mBio finds people who’ve had a COVID-19 infection and received a vaccine have high-quality antibodies that act against spike variants more effectively than either group alone.
Contact ASM Communications
Contact us to schedule an interview with an expert or to learn about the latest ASM research.Email Us